The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Soluble IL-6 Receptor Governs IL-6 Activity in Experimental Arthritis: Blockade of Arthritis Severity by Soluble Glycoprotein 130
Abstract
Studies in IL-6-deficient (IL-6−/−) mice highlight that IL-6 contributes to arthritis progression. However, the molecular mechanism controlling its activity in vivo remains unclear. Using an experimental arthritis model in IL-6−/− mice, we have established a critical role for the soluble IL-6R in joint inflammation. Although intra-articular administration of IL-6 itself was insufficient to reconstitute arthritis within these mice, a soluble IL-6R-IL-6 fusion protein (HYPER-IL-6) restored disease activity. Histopathological assessment of joint sections demonstrated that HYPER-IL-6 increased arthritis severity and controlled intrasynovial mononuclear leukocyte recruitment through the CC-chemokine CCL2. Activation of synovial fibroblasts by soluble IL-6R and IL-6 emphasized that these cells may represent the source of CCL2 in vivo. Specific blockade of soluble IL-6R signaling in wild-type mice using soluble gp130 ameliorated disease. Consequently, soluble IL-6R-mediated signaling represents a promising therapeutic target for the treatment of rheumatoid arthritis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chemokines and leukocyte traffic
Baggiolini, M. (1998) · Nature · doi:10.1038/33340 · Cited by 2,709
Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway
HEINRICH, P. C., BEHRMANN, I., MÜLLER-NEWEN, G., SCHAPER, F., & GRAEVE, L. (1998) · Biochemical Journal · doi:10.1042/bj3340297 · Cited by 2,130
Atreya, R., Mudter, J., Finotto, S., Müllberg, J., Jostock, T., Wirtz, S., Schütz, M., Bartsch, B., Holtmann, M., Becker, C., et al. (2000) · Nature Medicine · doi:10.1038/75068 · Cited by 1,293
Self-citationRole of IL-6 and Its Soluble Receptor in Induction of Chemokines and Leukocyte Recruitment
Romano, M., Sironi, M., Toniatti, C., Polentarutti, N., Fruscella, P., Ghezzi, P., Faggioni, R., Luini, W., van Hinsbergh, V., Sozzani, S., et al. (1997) · Immunity · doi:10.1016/s1074-7613(00)80334-9 · Cited by 1,112
Houssiau, F. A., Devogelaer, J., Damme, J. V., Deuxchaisnes, C. N. D., & Snick, J. V. (1988) · Arthritis & Rheumatism · doi:10.1002/art.1780310614 · Cited by 847
Hurst, S. M., Wilkinson, T. S., McLoughlin, R. M., Jones, S., Horiuchi, S., Yamamoto, N., Rose-John, S., Fuller, G. M., Topley, N., & Jones, S. A. (2001) · Immunity · doi:10.1016/s1074-7613(01)00151-0 · Cited by 811
Self-citationSoluble gp130 is the natural inhibitor of soluble interleukin‐6 receptor transsignaling responses
Jostock, T., Müllberg, J., Özbek, S., Atreya, R., Blinn, G., Voltz, N., Fischer, M., Neurath, M. F., & Rose‐John, S. (2001) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2001.01867.x · Cited by 641
Self-citationThe soluble interleukin 6 receptor: mechanisms of production and implications in disease
JONES, S. A., HORIUCHI, S., TOPLEY, N., YAMAMOTO, N., & FULLER, G. M. (2001) · The FASEB Journal · doi:10.1096/fj.99-1003rev · Cited by 623
Self-citationInterleukin 6 is required for the development of collagen-induced arthritis
Alonzi, T., Fattori, E., Lazzaro, D., Costa, P., Probert, L., Kollias, G., De Benedetti, F., Poli, V., & Ciliberto, G. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.4.461 · Cited by 604
Wipke, B. T., & Allen, P. M. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.3.1601 · Cited by 585
Production of collagenase and prostaglandins by isolated adherent rheumatoid synovial cells.
Dayer, J. M., Krane, S. M., Russell, R. G., & Robinson, D. R. (1976) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.73.3.945 · Cited by 550
Kotake, S., Sato, K., Kim, K. J., Takahashi, N., Udagawa, N., Nakamura, I., Yamaguchi, A., Kishimoto, T., Suda, T., & Kashiwazaki, S. (1996) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650110113 · Cited by 545
A bioactive designer cytokine for human hematopoietic progenitor cell expansion
Fischer, M., Goldschmitt, J., Peschel, C., Brakenhoff, J. P. G., Kallen, K.-J., Wollmer, A., Grötzinger, J., & Rose-John, S. (1997) · Nature Biotechnology · doi:10.1038/nbt0297-142 · Cited by 530
Self-citationChoy, E. H. S., Isenberg, D. A., Garrood, T., Farrow, S., Ioannou, Y., Bird, H., Cheung, N., Williams, B., Hazleman, B., Price, R., et al. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10623 · Cited by 526
Guerne, P. A., Zuraw, B. L., Vaughan, J. H., Carson, D. A., & Lotz, M. (1989) · Journal of Clinical Investigation · doi:10.1172/jci113921 · Cited by 513
Inhibition of T cell apoptosis in the rheumatoid synovium.
Salmon, M., Scheel-Toellner, D., Huissoon, A. P., Pilling, D., Shamsadeen, N., Hyde, H., D'Angeac, A. D., Bacon, P. A., Emery, P., & Akbar, A. N. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119178 · Cited by 469
Interleukin 6 plays a key role in the development of antigen-induced arthritis
Ohshima, S., Saeki, Y., Mima, T., Sasai, M., Nishioka, K., Nomura, S., Kopf, M., Katada, Y., Tanaka, T., Suemura, M., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.14.8222 · Cited by 406
Apoptosis as a therapeutic tool in rheumatoid arthritis
Pope, R. M. (2002) · Nature Reviews Immunology · doi:10.1038/nri846 · Cited by 401
Gong, J.-H., Ratkay, L. G., Waterfield, J. D., & Clark-Lewis, I. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.1.131 · Cited by 375
Madhok, R., Crilly, A., Watson, J., & Capell, H. A. (1993) · Annals of the Rheumatic Diseases · doi:10.1136/ard.52.3.232 · Cited by 340
Critical Roles for Interleukin 1 and Tumor Necrosis Factor α in Antibody-induced Arthritis
Ji, H., Pettit, A., Ohmura, K., Ortiz-Lopez, A., Duchatelle, V., Degott, C., Gravallese, E., Mathis, D., & Benoist, C. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020439 · Cited by 332
Peters, M., Jacobs, S., Ehlers, M., Vollmer, P., Müllberg, J., Wolf, E., Brem, G., Meyer zum Büschenfelde, K. H., & Rose-John, S. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.4.1399 · Cited by 276
Self-citationTreatment of severe rheumatoid arthritis by anti-interleukin 6 monoclonal antibody.
Wendling, D., Racadot, E., & Wijdenes, J. (1993) · PubMed · Cited by 274
Blockage of interleukin-6 receptor ameliorates joint disease in murine collagen-induced arthritis
Takagi, N., Mihara, M., Moriya, Y., Nishimoto, N., Yoshizaki, K., Kishimoto, T., Takeda, Y., & Ohsugi, Y. (1998) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199812)41:12<2117::aid-art6>3.0.co;2-p · Cited by 270
Jones, S. A., & Rose-John, S. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(02)00319-1 · Cited by 255
Self-citationIL-6 rescues resting mouse T cells from apoptosis
Teague, T. K., Marrack, P., Kappler, J. W., & Vella, A. T. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.12.5791 · Cited by 248
Delayed onset and reduced severity of collagen-induced arthritis in interleukin-6-deficient mice
Sasai, M., Saeki, Y., Ohshima, S., Nishioka, K., Mima, T., Tanaka, T., Katada, Y., Yoshizaki, K., Suemura, M., & Kishimoto, T. (1999) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199908)42:8<1635::aid-anr11>3.0.co;2-q · Cited by 227
Atsumi, T., Ishihara, K., Kamimura, D., Ikushima, H., Ohtani, T., Hirota, S., Kobayashi, H., Park, S.-J., Saeki, Y., Kitamura, Y., et al. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020619 · Cited by 225 · cited 1×
“Indeed, development of autoimmune arthritis in mice possessing a mutated gp130 subunit has been related to the inability of the T cell population to undergo apoptosisinduced cell death (50).”
BackgroundMarin, V., Montero-Julian, F. A., Grès, S., Boulay, V., Bongrand, P., Farnarier, C., & Kaplanski, G. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.6.3435 · Cited by 204
Modur, V, Li, Y., Zimmerman, G. A., Prescott, S. M., & McIntyre, T. M. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119821 · Cited by 204
Circadian rhythm of serum interleukin-6 in rheumatoid arthritis.
Arvidson, N. G., Gudbjörnsson, B., Elfman, L., Rydén, A. C., Tötterman, T. H., & Hällgren, R. (1994) · Annals of the Rheumatic Diseases · doi:10.1136/ard.53.8.521 · Cited by 201
MIHARA, M., MORIYA, Y., KISHIMOTO, T., & OHSUGI, Y. (1995) · Rheumatology · doi:10.1093/rheumatology/34.4.321 · Cited by 198
Horiuchi, S., Koyanagiu, Y., Zhouu, Y., Miyamotou, H., Tanakau, Y., Waki, M., Matsumoto, A., Yamamotou, M., & Yamamotof, N. (1994) · European Journal of Immunology · doi:10.1002/eji.1830240837 · Cited by 197
Self-citationC-reactive Protein: A Physiological Activator of Interleukin 6 Receptor Shedding
Jones, S. A., Novick, D., Horiuchi, S., Yamamoto, N., Szalai, A. J., & Fuller, G. M. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.3.599 · Cited by 196
Self-citationRobak, T., Gladalska, A., Stepień, H., & Robak, E. (1998) · Mediators of Inflammation · doi:10.1080/09629359890875 · Cited by 161
INTERLEUKIN 6 KNOCK-OUT MICE ARE RESISTANT TO ANTIGEN-INDUCED EXPERIMENTAL ARTHRITIS
Boe, A., Baiocchi, M., Carbonatto, M., Papoian, R., & Serlupi‐Crescenzi, O. (1999) · Cytokine · doi:10.1006/cyto.1999.0502 · Cited by 142
Concentrations and origins of soluble interleukin 6 receptor-alpha in serum and synovial fluid.
Desgeorges, A., Gabay, C., Silacci, P., Novick, D., Roux-Lombard, P., Grau, G. E., Dayer, J. M., VISCHER, T. L., & Guerne, P. A. (1997) · PubMed · Cited by 134
Manicourt, D.-H., Triki, R., Fukuda, K., Devogelaer, J., de Deuxchaisnes, C. N., & Thonar, E. J. ‐. A. (1993) · Arthritis & Rheumatism · doi:10.1002/art.1780360409 · Cited by 134
Flannery, C. R., Little, C. B., Hughes, C., Curtis, C. L., Caterson, B., & Jones, S. A. (2000) · Matrix Biology · doi:10.1016/s0945-053x(00)00111-6 · Cited by 131
Self-citationLi, F. K., Davenport, A., Robson, R. L., Loetscher, P., Rothlein, R., Williams, J. D., & Topley, N. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00174.x · Cited by 126
Self-citationKlouche, M., Rose‐John, S., Schmiedt, W., & Bhakdi, S. (2000) · Circulation · doi:10.1161/01.cir.101.15.1799 · Cited by 125
Self-citationvan de Loo, F. A. J., Kuiper, S., van Enckevort, F. H. J., Arntz, O. J., & van den Berg, W. B. (1997) · Europe PMC (PubMed Central) · Cited by 115
Suzuki, H., Yasukawa, K., Saito, T., Narazaki, M., Hasegawa, A., Taga, T., & Kishimoto, T. (1993) · European Journal of Immunology · doi:10.1002/eji.1830230515 · Cited by 103
Role of IL-6 and the Soluble IL-6 Receptor in Inhibition of VCAM-1 Gene Expression
Oh, J., Wagoner, N. J. V., Rose‐John, S., & Benveniste, E. N. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.9.4992 · Cited by 102
Self-citationKeul, R., Heinrich, P. C., Müller-Newen, G., Muller, K., & Woo, P. (1998) · Cytokine · doi:10.1006/cyto.1997.0343 · Cited by 98
Mihara, M., Kotoh, M., Nishimoto, N., Oda, Y., Kumagai, E., Takagi, N., Tsunemi, K., Ohsugi, Y., Kishimoto, T., Yoshizaki, K., et al. (2001) · Clinical Immunology · doi:10.1006/clim.2000.4989 · Cited by 94
Franchimont, N., Rydziel, S., Delany, A. M., & CANALIS, E. M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.18.12144 · Cited by 78
de Hooge, A. S. K., van de Loo, F. V. D., Arntz, O., & van den Berg, W. (2000) · American Journal of Pathology · doi:10.1016/s0002-9440(10)64846-8 · Cited by 78
Tanaka, M., Kishimura, M., Ozaki, S., Osakada, F., Hashimoto, H., Okubo, M., Murakami, M., & Nakao, K. (2000) · Journal of Clinical Investigation · doi:10.1172/jci7479 · Cited by 69
Matsumiya, T., Imaizumi, T., Fujimoto, K., Cui, X., Shibata, T., Tamo, W., Kumagai, M., Tanji, K., Yoshida, H., Kimura, H., et al. (2001) · Experimental Cell Research · doi:10.1006/excr.2001.5300 · Cited by 48
HORIUCHI, AMPOFO, Koyanagi, Yamashita, Waki, MATSUMOTO, YAMAMOTO, & YAMAMOTO (1998) · Immunology · doi:10.1046/j.1365-2567.1998.00622.x · Cited by 34
Cited by
The pro- and anti-inflammatory properties of the cytokine interleukin-6
Scheller, J., Chalaris, A., Schmidt-Arras, D., & Rose-John, S. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2011.01.034 · Cited by 3,212
Self-citationRecent insights into targeting the IL-6 cytokine family in inflammatory diseases and cancer
Jones, S. A., & Jenkins, B. J. (2018) · Nature Reviews Immunology · doi:10.1038/s41577-018-0066-7 · Cited by 1,102
Self-citationInterleukin-6, a Major Cytokine in the Central Nervous System
Erta, M., Quintana, A., & Hidalgo, J. (2012) · International Journal of Biological Sciences · doi:10.7150/ijbs.4679 · Cited by 1,087
Rose-John, S. (2012) · International Journal of Biological Sciences · doi:10.7150/ijbs.4989 · Cited by 1,040
“Rheumatoid Arthritis Antigen induced arthritis, collagen induced arthritis [8, 34, 64]”
BackgroundSelf-citationInterleukin-6 Family Cytokines
Rose-John, S. (2018) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a028415 · Cited by 799
Self-citation
Metadata
- Authors
- Nowell, M. A., Richards, P. J., Horiuchi, S., Yamamoto, N., Rose-John, S., Topley, N., Williams, A. S., & Jones, S. A.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-09
- Volume
- 171
- Issue
- 6
- Pages
- 3202-3209
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1849537180
- Cited by
- 268
- References
- 51
- FWCI
- 7.29
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.